DB18413InvestigationalProtein Based Therapies
KUR-113 is an investigational fibrin-based agent containing an N-terminally modified parathyroid hormone fragment. It is being investigated as a bioactive bone graft substitute.
- Also known as
- Fibrin-based agent containing a N-terminally modified parathyroid hormone fragment TGplPTH1-34 · Fibrin-PTH
- Code names
- KUR-113
What you can answer from here — as of April 23, 2025
Which companies are running trials of KUR-113, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account